Overview
Molecule is the infrastructure layer of decentralized science, providing the IP-NFT framework that underpins most biotech DAOs. The platform lets research communities fund biomedical research and trade the resulting intellectual property on-chain, turning years of locked, illiquid scientific output into assets with price discovery and secondary markets.
Molecule's core innovation is attaching legal IP rights to an NFT, creating an asset class that a community can co-own and govern. The platform spans longevity, brain health, women's health, psychedelics, cell therapy and climate research, and is the tokenization engine behind the Bio Protocol BioDAO ecosystem.
How IP-NFTs and IP Tokens work
An IP-NFT is a single non-fungible token that carries the legal rights to a research project — its data, licensing terms and any downstream commercial upside. Molecule's open-source IP-NFT contracts reached V2 in 2024, standardizing this as reusable building blocks for the DeSci economy.
A single NFT is a poor governance and funding instrument, so Molecule added a Tokenizer contract that minted an ERC-20 IP Token (IPT) against an IP-NFT. Fractionalizing the IP-NFT into IPTs distributed ownership across many holders, funded the research through their purchases, and let that group of holders collectively govern the asset as it moved through the R&D pipeline. IPTs can also gate access to proprietary data and route IP-licensing revenue back to holders.
This is the on-chain analogue of a cap table for a research program — a design that sits squarely inside the DAO tokenomics question of how a token confers real economic and governance rights rather than pure speculation. In 2025 Molecule extended the model toward bridging tokenized IP into the wider real-world-asset (RWA) market.
V3: the Lab replaces the IP-NFT
That first-generation stack is now history. Molecule's contract index heads its Ethereum and Sepolia IPNFT sections “UNMAINTAINED” and lists the live deployment as “Molecule Labs core (v0.1.0)” on Base. The V3 primitive is a Lab: “an NFT (ERC-721) that is permanently bound to its own smart contract wallet (ERC-6551)” with account abstraction (ERC-4337), installable modules (ERC-7579) and an attestation registry (ERC-7484) gating what can be installed. The research project is no longer a token pointing at an asset; it is an account that holds its own treasury, data anchor and licences, and transferring the LabNFT hands over the whole thing in one ERC-721 transfer.
Tokenization moved with it: the OclTokenizer deploys one fractional ERC-20 IP Token per Lab, gated by a signed membership agreement, each as an EIP-1167 clone with its own address. Molecule also documents a Coin-to-Company module that states plainly that “Tokens are not equity” and routes holders who want shares through a lock-and-KYC path into ordinary off-chain share agreements. The full generational comparison is on the IP-NFTs and IP Tokens page.
How much of that V3 stack is in use is measurable. On 12 October 2026 the LabNFT contract reported 151 Labs, the first of them minted on 8 July 2026. The OclTokenizer has issued five IP Tokens, the first on 18 September, two months after the tokenizer was set up on 16 July, and none since 6 October. Its account nonce reads 6, because a contract's nonce starts at 1 and rises each time it creates a contract, and each IP Token is an EIP-1167 clone the tokenizer deploys. The IP-NFTs and IP Tokens page lists the five, with the Lab each was issued for, and the method.
IP as a treasury asset
For a science DAO, the tokenized IP is not a side product — it is the treasury's core holding. A VitaDAO or AthenaDAO funds a study, receives an IP-NFT, and that asset (plus any licensing income) is what the community stewards. This makes treasury management for a DeSci DAO a question of managing a portfolio of illiquid, high-variance research bets rather than a stack of liquid tokens, and it is why the Molecule + Bio Protocol stack pairs IP tokenization with a launchpad and staking layer that keeps the community funding and curating the pipeline.
Products
Molecule Labs: the platform at labs.molecule.xyz, where researchers create and manage Labs — the on-chain research accounts that hold a project's token, treasury and data room.
Data rooms and access control: research files are client-side encrypted and released against on-chain conditions, with roles and expiry resolved by the AccessResolver — the mechanism that lets a Lab grant a collaborator or an AI agent scoped, expiring access without handing over ownership.
Documentation and contracts: developer and concept guides at docs.molecule.xyz, with the legacy IP-NFT contracts and subgraphs at github.com/moleculeprotocol/IPNFT.
Pump.science: Molecule founder/CEO Paul Kohlhaas also launched Pump.science, a Solana tokenized-experiment launchpad that funds longevity compound trials through freely tradeable tokens (Unchained) — the market-driven counterpart to Molecule's deliberative model.
How Caper approaches this
Molecule solves the asset side of DeSci — making research IP ownable and tradable. A caper addresses the organization side: it folds the fundraise (a bonding-curve sale), the treasury, on-chain proposals (PAYOUT / INVEST / DIVEST / METADATA) and an exit weighted by participation into one primitive. The two do not sit in one wallet. A Lab and its IP Token live on Base and the original IP-NFTs on Ethereum, while a caper and its treasury live on Radix, so a research community cannot deposit its Lab into a caper.
What it can do is split the work: the caper raises the money, holds it and decides by proposal what to pay for, while the IP stays with Molecule and is licensed off-chain by the collective, as the IP-NFTs page sets out. A caper's exit pays a leaving member a share of each treasury balance, rounded down to whole units, so one NFT held there could not be split among the members who leave.